文献速递精神分裂症与精神病性障碍

精神分裂症的基因组学发现及其意义

Genomic findings in schizophrenia and their implications.
PubMed 文献 · Mol Psychiatry · 2023-10-18

该综述总结近15年精神分裂症遗传学进展,指出该病高度多基因,大部分可解释遗传力来自微效常见等位基因,另有罕见拷贝数与编码变异贡献。已定位的基因与位点指向神经元尤其突触功能异常,并揭示其与双相障碍、儿童神经发育障碍的密切关系及常见风险等位基因在低生育力下维持的机制。当前基因组方法仅潜在解释约40%遗传力,其中仅小部分归因于稳健识别位点,极端多基因性与高多效性对机制理解、跨诊断研究和因果推断构成挑战,且研究存在欧洲中心偏倚。

要点

  • 精神分裂症为高度多基因疾病,常见微效等位基因贡献主要可解释遗传力,罕见拷贝数与编码变异另有贡献。
  • 已定位基因与位点指向神经元尤其突触功能异常,不局限于少数脑区与环路。
  • 遗传发现揭示与双相障碍、儿童神经发育障碍的密切关系,并解释常见风险等位基因在低生育力下的维持。

核心结论

  • 精神分裂症是高度多基因疾病,常见微效等位基因贡献主要可解释遗传力,罕见拷贝数与编码变异另有贡献。
  • 已定位基因与位点指向神经元尤其突触功能异常,不局限于少数脑区与环路。
  • 遗传发现揭示与双相障碍、儿童神经发育障碍的密切关系,并解释常见风险等位基因在低生育力下的维持。
  • 当前基因组方法仅潜在解释约40%遗传力,其中仅小部分归因于稳健识别位点。
  • 极端多基因性与高多效性要求跨诊断研究,并提示当前诊断标准难以划分生物学 distinct 分层。

研究设计与样本

  • 本文为综述,总结近15年精神分裂症遗传学研究成果。

主要发现

  • 精神分裂症为高度多基因疾病,多数可解释遗传力来自微效常见等位基因,罕见拷贝数与编码变异另有贡献。
  • 已定位的特定基因与位点指向神经元尤其突触功能异常,不局限于少数脑区与环路。
  • 遗传发现揭示精神分裂症与双相障碍、儿童神经发育障碍的密切关系,并解释常见风险等位基因在低生育力下如何维持。
  • 当前基因组方法仅潜在解释约40%遗传力,其中仅小部分归因于稳健识别位点。
  • 极端多基因性与高多效性对理解生物学机制、跨诊断研究及因果推断构成挑战,且基因组研究存在欧洲中心偏倚。

关键数值与推荐

  • 当前基因组方法仅潜在解释约40%遗传力,其中仅小部分归因于稳健识别位点。

临床怎么用

  • 临床应认识精神分裂症的高度多基因性与高多效性,理解当前遗传发现尚不足以划分生物学 distinct 分层。
  • 遗传发现提示跨诊断研究必要性,并应关注研究样本的欧洲中心偏倚问题。
  • 未来需结合全基因组与长读长测序、功能基因组学与蛋白质组学及精细表型数据以推进机制理解。

局限性

  • 当前基因组方法仅潜在解释约40%遗传力,其中仅小部分归因于稳健识别位点。
  • 极端多基因性对理解生物学机制构成挑战。
  • 高多效性提示当前诊断标准难以划分生物学 distinct 分层,并对因果推断构成挑战。
  • 基因组研究存在欧洲中心偏倚,需纠正以最大化收益并确保惠及多样社区。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

There has been substantial progress in understanding the genetics of schizophrenia over the past 15 years. This has revealed a highly polygenic condition with the majority of the currently explained heritability coming from common alleles of small effect but with additional contributions from rare copy number and coding variants. Many specific genes and loci have been implicated that provide a firm basis upon which mechanistic research can proceed. These point to disturbances in neuronal, and particularly synaptic, functions that are not confined to a small number of brain regions and circuits. Genetic findings have also revealed the nature of schizophrenia's close relationship to other conditions, particularly bipolar disorder and childhood neurodevelopmental disorders, and provided an explanation for how common risk alleles persist in the population in the face of reduced fecundity. Current genomic approaches only potentially explain around 40% of heritability, but only a small proportion of this is attributable to robustly identified loci. The extreme polygenicity poses challenges for understanding biological mechanisms. The high degree of pleiotropy points to the need for more transdiagnostic research and the shortcomings of current diagnostic criteria as means of delineating biologically distinct strata. It also poses challenges for inferring causality in observational and experimental studies in both humans and model systems. Finally, the Eurocentric bias of genomic studies needs to be rectified to maximise benefits and ensure these are felt across diverse communities. Further advances are likely to come through the application of new and emerging technologies, such as whole-genome and long-read sequencing, to large and diverse samples. Substantive progress in biological understanding will require parallel advances in functional genomics and proteomics applied to the brain across developmental stages. For these efforts to succeed in identifying disease mechanisms and defining novel strata they will need to be combined with sufficiently granular phenotypic data.

来源:Mol Psychiatry,查看原文。版权归原作者所有。

引用

  1. Owen MJ, Legge SE, Rees E, et al. Genomic findings in schizophrenia and their implications. Mol Psychiatry. 2023. PMID: 37853064. doi:10.1038/s41380-023-02293-8

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。